go back

Prostate Cancer Antibody Response Score

Delaware rates for HCPCS 0021U

Assesses the likelihood of prostate cancer by measuring the immune system's antibody response to eight tumor-associated proteins, including ARF6, NKX3-1, BMI1, CEP164, Ropporin, desmocollin, AURKAIP-1 and CSNK2A2. The eight results are combined into a single risk score, and no genetic material is examined.

Facilitymedian $871 · 10th–90th $871$8710%50%$871Professionalmedian $631 · 10th–90th $589$7590%20%40%10th90th$631$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$870.96
Median
$870.96
Typical High
$870.96
Aetna
Setting
Professional
Modifier
Global
Typical Low
$588.84
Median
$630.96
Typical High
$758.58
Cigna
Setting
Facility
Modifier
Global
Typical Low
$489.78
Median
$489.78
Typical High
$489.78
Cigna
Setting
Professional
Modifier
Global
Typical Low
$870.96
Median
$870.96
Typical High
$1,096.48
United
Setting
Professional
Modifier
Global
Typical Low
$316.23
Median
$457.09
Typical High
$758.58